21428015|t|[Drug treatment of dementia with Lewy bodies and Parkinson's disease dementia--common features and differences].
21428015|a|Dementia with Lewy-bodies (DLB) and Parkinson's disease dementia (PDD) are no rare causes of dementia. Both have neuropathologically, clinically, and neurochemically much in common. In the course of both conditions frequently psychotic symptoms occur, often induced by antiparkinsonian medication. Treatment of psychotic features with conventional antipsychotics is not tolerated in many cases. Therefore low-dose clozapine treatment is acknowledged usual practise for psychosis in Parkinson's disease and a case report indicates efficacy for psychosis in DLB, too. All other atypical antipsychotics except risperidone are not licensed for dementia in Germany, but risperidone is contraindicated in DLB due to manufacturer's notice and usually not well tolerated in DLB and Parkinson's disease. Open trials indicate safety for treatment of psychosis in DLB and PDD with quetiapine. Randomized controlled trials indicate, that quetiapine is less effective than clozapine against psychotic symptoms in both conditions, although comparatively safe. Cholinesterase inhibitors, especially rivastigmine, are a therapeutic alternative for treating both psychotic and cognitive symptoms in both conditions. Parkinsonism in DLB-patients responds worse to levodopa compared to patient with Parkinson's disease. Anticholinergic drugs often induce delirium in demented patients and therefore should be avoided. The same problem is associated with dopamine agonists in PDD and DLB. Amantadine, a NMDA-receptor antagonist like memantine, potentially bears the same risk of worsening psychotic symptoms. The following preliminary recommendation for drug treatment of PDD and DLB can be given: Stop all anticholinergic medication and reduce levodopa and other antiparkinsonian medication to the tolerated minimum. Levodopa alone is preferred. Treat with cholinesterase inhibitors to the maximum tolerated dose. If there is no adequate response regarding psychotic symptoms, add quetiapine. If this approach fails, replace quetiapine by low-dose clozapine. If behavioural disturbances are due to depression, anxiety, or irritability, treatment with an antidepressant, preferably citalopram, is an option.
21428015	19	44	dementia with Lewy bodies	Disease	MESH:D020961
21428015	49	77	Parkinson's disease dementia	Disease	MESH:D010300
21428015	113	138	Dementia with Lewy-bodies	Disease	MESH:D020961
21428015	140	143	DLB	Disease	MESH:D020961
21428015	149	177	Parkinson's disease dementia	Disease	MESH:D010300
21428015	179	182	PDD	Disease	MESH:D010300
21428015	206	214	dementia	Disease	MESH:D003704
21428015	339	357	psychotic symptoms	Disease	MESH:D011618
21428015	424	442	psychotic features	Disease	MESH:D019967
21428015	527	536	clozapine	Chemical	MESH:D003024
21428015	582	591	psychosis	Disease	MESH:D011618
21428015	595	614	Parkinson's disease	Disease	MESH:D010300
21428015	656	665	psychosis	Disease	MESH:D011618
21428015	669	672	DLB	Disease	MESH:D020961
21428015	720	731	risperidone	Chemical	MESH:D018967
21428015	753	761	dementia	Disease	MESH:D003704
21428015	778	789	risperidone	Chemical	MESH:D018967
21428015	812	815	DLB	Disease	MESH:D020961
21428015	879	882	DLB	Disease	MESH:D020961
21428015	887	906	Parkinson's disease	Disease	MESH:D010300
21428015	953	962	psychosis	Disease	MESH:D011618
21428015	966	969	DLB	Disease	MESH:D020961
21428015	974	977	PDD	Disease	MESH:D010300
21428015	983	993	quetiapine	Chemical	MESH:D000069348
21428015	1039	1049	quetiapine	Chemical	MESH:D000069348
21428015	1073	1082	clozapine	Chemical	MESH:D003024
21428015	1091	1109	psychotic symptoms	Disease	MESH:D011618
21428015	1197	1209	rivastigmine	Chemical	MESH:D000068836
21428015	1259	1291	psychotic and cognitive symptoms	Disease	MESH:D019954
21428015	1312	1324	Parkinsonism	Disease	MESH:D010302
21428015	1328	1331	DLB	Disease	MESH:D020961
21428015	1332	1340	patients	Species	9606
21428015	1359	1367	levodopa	Chemical	MESH:D007980
21428015	1380	1387	patient	Species	9606
21428015	1393	1412	Parkinson's disease	Disease	MESH:D010300
21428015	1449	1457	delirium	Disease	MESH:D003693
21428015	1470	1478	patients	Species	9606
21428015	1548	1556	dopamine	Chemical	MESH:D004298
21428015	1569	1572	PDD	Disease	MESH:D010300
21428015	1577	1580	DLB	Disease	MESH:D020961
21428015	1582	1592	Amantadine	Chemical	MESH:D000547
21428015	1626	1635	memantine	Chemical	MESH:D008559
21428015	1682	1700	psychotic symptoms	Disease	MESH:D011618
21428015	1765	1768	PDD	Disease	MESH:D010300
21428015	1773	1776	DLB	Disease	MESH:D020961
21428015	1838	1846	levodopa	Chemical	MESH:D007980
21428015	1911	1919	Levodopa	Chemical	MESH:D007980
21428015	2051	2069	psychotic symptoms	Disease	MESH:D011618
21428015	2075	2085	quetiapine	Chemical	MESH:D000069348
21428015	2119	2129	quetiapine	Chemical	MESH:D000069348
21428015	2142	2151	clozapine	Chemical	MESH:D003024
21428015	2156	2180	behavioural disturbances	Disease	MESH:D014832
21428015	2192	2202	depression	Disease	MESH:D003866
21428015	2204	2211	anxiety	Disease	MESH:D001007
21428015	2216	2228	irritability	Disease	MESH:D001523
21428015	2275	2285	citalopram	Chemical	MESH:D015283
21428015	Negative_Correlation	MESH:D015283	MESH:D001523
21428015	Negative_Correlation	MESH:D018967	MESH:D020961
21428015	Negative_Correlation	MESH:D015283	MESH:D001007
21428015	Negative_Correlation	MESH:D000069348	MESH:D020961
21428015	Negative_Correlation	MESH:D003024	MESH:D011618
21428015	Negative_Correlation	MESH:D015283	MESH:D003866
21428015	Negative_Correlation	MESH:D007980	MESH:D010300
21428015	Positive_Correlation	MESH:D008559	MESH:D011618
21428015	Negative_Correlation	MESH:D007980	MESH:D020961
21428015	Comparison	MESH:D000069348	MESH:D003024
21428015	Negative_Correlation	MESH:D000069348	MESH:D011618
21428015	Negative_Correlation	MESH:D000068836	MESH:D019954
21428015	Negative_Correlation	MESH:D000069348	MESH:D010300
21428015	Negative_Correlation	MESH:D007980	MESH:D010302
21428015	Positive_Correlation	MESH:D000547	MESH:D011618
21428015	Negative_Correlation	MESH:D015283	MESH:D014832
21428015	Negative_Correlation	MESH:D003024	MESH:D010300
21428015	Negative_Correlation	MESH:D003024	MESH:D019967
21428015	Association	MESH:D004298	MESH:D010300
21428015	Negative_Correlation	MESH:D000068836	MESH:D011618
21428015	Negative_Correlation	MESH:D000068836	MESH:D020961

